Wang Y, Li S, Pan Y, et al. Tenecteplase versus alteplase in acute ischaemic cerebrovascular
events (TRACE-2): a phase 3, multicentre, open-label, randomised controlled, non-inferiority
trial. Lancet 2023; 401: 645–54 In this Article the fourth sentence of the Role of
the funding source section should read “The Clinical Research Institute of Peking
University was responsible for the statistical analysis” and the Acknowledgments should
have included Chen Yao and his team. These corrections have been made to the online
version as of March 30, 2023.
The 19th Tore Godal prize awards - Capital Newspaper capitalethiopia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from capitalethiopia.com Daily Mail and Mail on Sunday newspapers.
PARIS (BUSINESS WIRE) Regulatory News:ACTICOR BIOTECH (ISIN: FR0014005OJ5 - ALACT) (Paris:ALACT), a clinical-stage biotechnology company focused on the development of innovative drugs for the treatment of cardiovascular emergencies, in particular stroke, is announcing today the appointment of Patricia Zilliox as a.
Patients with cholestatic liver disease such as primary biliary cholangitis (PBC) can experience significant impairment of bile flow and may develop neurological symptoms including fatigue and cognitive decline.